Cochrane COVID-19 Study Register
Study record
NCT05043350First Published: 2021 Sep 14Updated Date: 2021 Sep 14

Potential Therapeutic Outcome of Combined Antihistaminics Therapy in COVID 19 Patients

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
Reference record

Combined Antihistaminics Therapy in COVID 19 Patients

Ain Shams University
First Published (first received 2021 September 14)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT05043350)
Trial registry record
No Results
The use of antihistaminic medications could result in a significant immune modulation which may help in the treatment of cytokine storm of COVID-19.Thus, the aim of this study is to evaluate efficacy and safety of famotidine and loratadine combination in covid 19 treatment protocol